From July 1, 2023 to September 30, 2023, the company has repurchased 175,910 shares, representing 0.22% for $0.4 million. With this, the company has completed the repurchase of 3,056,903 shares, representing 3.86% for $5.8 million under the buyback announced on November 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.4 USD | -0.41% | -4.38% | +8.60% |
08/05 | Transcript : Standard BioTools Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, vs. Street Est of $46M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.60% | 918M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- LAB Stock
- News Standard BioTools Inc.
- Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on November 28, 2022.